TeleNEURO-Rehabilitation Systems for Neurodegenerative Conditions: the FIT4TeleNEURO Pragmatic Trial

NCT ID: NCT06685744

Last Updated: 2025-03-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-23

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of the FIT4TeleNEURO pragmatic trial is to verify, in real-life care contexts, the superiority in terms of the effectiveness of early rehabilitation intervention with Telerehabilitation (TR) protocols (TR single Approach, task-oriented - TRsA; TR combined approach, task-oriented and impairment-oriented - TRcA) compared to conventional management (Educational treatment, ET).

The main questions it aims to answer are:

* Are Telerehabilitation protocols more effective than educational treatment?
* Is the TRcA treatment more effective than the TRsA? The study investigates the effects of rehabilitation treatment by comparing the two target cases (Multiple Sclerosis - MS and Parkinson's Diseases - PD).

Participants will be subjective to:

* 3 time-point of assessment (baseline, post-treatment and follow up) with motor, cognitive and quality-of-life measures
* A 5-weeks rehabilitation treatment (4 times/week)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease Multiple Sclerosis Neurologic Diseases, General

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TRsA

Telerehabilitation (TR) single Approach - TRsA

Group Type EXPERIMENTAL

Telerehabilitation_TRsA

Intervention Type DEVICE

Frequency: 5 weeks (4 sessions/week) of Telerehabilitation intervention provided according to a mixed model (3 asynchronous sessions + 1 synchronous session/week); Intensity: customized according to the patient's functional abilities (system's feedback); Time: 50 minutes/session; Type: exercises aimed at improving functional mobility and physical capacity according to a Task-oriented approach.

TRcA

Telerehabilitation (TR) combined Approach - TRcA

Group Type EXPERIMENTAL

Telerehabilitation_TRcA

Intervention Type DEVICE

Frequency: 5 weeks (4 sessions/week) of Telerehabilitation intervention provided according to a mixed model (3 asynchronous sessions + 1 synchronous session/week); Intensity: customized according to the patient's functional abilities (system's feedback); Time: 50 minutes/session; Type: a combination of exercises aimed at improving functional mobility and physical capacity according to a Task-oriented approach together with exercises aimed at recovering muscle strength (resistance) and improving endurance (endurance) using an Impairment-oriented approach.

ET

Educational treatment - ET

Group Type PLACEBO_COMPARATOR

Educational treatment

Intervention Type BEHAVIORAL

Home rehabilitation indications according to a conventional approach, customized according to the disease.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Telerehabilitation_TRsA

Frequency: 5 weeks (4 sessions/week) of Telerehabilitation intervention provided according to a mixed model (3 asynchronous sessions + 1 synchronous session/week); Intensity: customized according to the patient's functional abilities (system's feedback); Time: 50 minutes/session; Type: exercises aimed at improving functional mobility and physical capacity according to a Task-oriented approach.

Intervention Type DEVICE

Educational treatment

Home rehabilitation indications according to a conventional approach, customized according to the disease.

Intervention Type BEHAVIORAL

Telerehabilitation_TRcA

Frequency: 5 weeks (4 sessions/week) of Telerehabilitation intervention provided according to a mixed model (3 asynchronous sessions + 1 synchronous session/week); Intensity: customized according to the patient's functional abilities (system's feedback); Time: 50 minutes/session; Type: a combination of exercises aimed at improving functional mobility and physical capacity according to a Task-oriented approach together with exercises aimed at recovering muscle strength (resistance) and improving endurance (endurance) using an Impairment-oriented approach.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Telemedicine Digital Medicine Placebo treatment Telemedicine Digital medicine

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* diagnosis of probable PD according to MDS criteria (Postuma et al., 2015) in staging between 1 and 3 on the Hoehn \& Yahr scale (Goetz et al., 2004) or diagnosis of MS according to the criteria of MC Donald 2010 (Polman et al., 2011) with disability level at the Expanded Disability Status Scale EDSS (Kurtzke, 1983) ≤ 4.5;
* age between 25 and 85 years;
* preserved cognitive level at the Montreal Cognitive Assessment test (MoCA test \>15.5) (Santangelo et al., 2015);
* no rehabilitation program in place at the time of enrolment;
* stable drug treatment (last three month) with L-Dopa or dopamine agonists (PD group) or Disease Modifying Therapies (DMTs) (MS group).

Exclusion Criteria

* presence of comorbidities that might prevent patients from undertaking a safe home program or determining clinical instability (i.e., severe orthopedic or severe cognitive deficits);
* presence of major psychiatric complications or personality disorders;
* presence of severe impairment of visual and/or acoustic perception;
* falls resulting in injuries or more than 2 falls in the 6 months prior to recruitment (PD and MS groups).
* pregnancy
* relapse ongoing/at least 3 months since the last relapse (MS group);
* presence of "frequent" freezing as recorded at the administration of Section II (daily life activity) of the UPDRS (score ≥ 3) (PD group);
* EDSS-FS (cerebellar function) ≥ 3 (MS group).
Minimum Eligible Age

25 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fondazione Don Carlo Gnocchi Onlus, IRCCS Milano

UNKNOWN

Sponsor Role collaborator

Fondazione Don Carlo Gnocchi Onlus, Centro S Maria della Provvidenza, Roma

UNKNOWN

Sponsor Role collaborator

Fondazione Mondino

OTHER

Sponsor Role collaborator

Istituti Clinici Scientifici Maugeri SpA, IRCCS Bari

UNKNOWN

Sponsor Role collaborator

Istituti Clinici Scientifici Maugeri SpA, IRCCS Pavia

UNKNOWN

Sponsor Role collaborator

Istituti Clinici Scientifici Maugeri SpA, IRCCS Milano

UNKNOWN

Sponsor Role collaborator

Istituti Clinici Scientifici Maugeri SpA, IRCCS Montescano

UNKNOWN

Sponsor Role collaborator

Istituti Clinici Scientifici Maugeri SpA, IRCCS Telese

UNKNOWN

Sponsor Role collaborator

IRCCS Azienda Ospedaliera Universitaria San Martino - Genova

UNKNOWN

Sponsor Role collaborator

University of Modena and Reggio Emilia

OTHER

Sponsor Role collaborator

Centro Riabilitativo Villa Beretta

UNKNOWN

Sponsor Role collaborator

Fondazione Don Carlo Gnocchi Onlus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Istituti Clinici Scientifici Maugeri SpA

Bari, , Italy

Site Status RECRUITING

IRCCS Azienda Ospedaliera Universitaria San Martino

Genova, , Italy

Site Status RECRUITING

Centro Riabilitativo Villa Beretta

Lecco, , Italy

Site Status RECRUITING

Fondazione Don Carlo Gnocchi Onlus, IRCCS

Milan, , Italy

Site Status RECRUITING

University of Modena and Reggio Emilia

Modena, , Italy

Site Status RECRUITING

Istituto Neurologico Nazionale IRCCS Casimiro Mondino

Pavia, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

FRANCESCA BAGLIO, MD FRANCESCA BAGLIO, MD

Role: CONTACT

00390240308952

FEDERICA ROSSETTO, PhD

Role: CONTACT

00390240308952

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Stefania De Trane, MD

Role: primary

Angelo Schenone, MD

Role: primary

Franco Molteni, MD

Role: primary

Chiara Fanciullacci, Clinical Trial office

Role: primary

00390240308952

Giovanna Zamboni [email protected], MD

Role: primary

Roberto Deicco, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FIT4TeleNEURO

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.